The Coronary Artery Calcium (CAC) Score: A Direct Look at Your Heart Risk

Most heart-risk tools are educated guesses: feed in your age, cholesterol and blood pressure, and a calculator estimates your odds. A coronary artery calcium scan does something different — it looks directly at your arteries and shows whether disease is actually there. For the many people stuck in the "maybe you need a statin, maybe you don't" middle, that direct look can settle the question. This is a plain-language guide to what a CAC scan measures, how to read it, and who it's actually for. It's general education, not medical advice.

What is a CAC scan?

A coronary artery calcium (CAC) scan is a quick, low-dose CT of the heart — no injection, no treadmill, just a few breath-holds. It detects calcified plaque in the coronary arteries and quantifies it with the Agatston score ¹. The key idea is that it visualises atherosclerosis directly rather than estimating risk from surrogates like cholesterol. Calcium in a coronary artery is a fingerprint of established plaque — so the more there is, the more disease has built up ³.

Reading the score: the Agatston bands

The score sorts plaque burden into bands ³:

Crucially, adding CAC to a standard risk calculator reclassifies people — moving them up or down a risk category and catching events the calculator alone would miss, the central finding of the large MESA study ³. A high score (≥400) signals extensive disease and argues for aggressive prevention; the hazard for events climbs steeply across the bands ³.

The "power of zero"

The single most useful result for many people is zero. A CAC of 0 means no detectable calcified plaque — and it confers a very low risk of heart events for the next decade or more, a kind of "warranty period" ⁴. In practice, for an intermediate-risk person on the fence about a statin, a score of zero can justify safely holding off and rechecking in five to ten years ². The number-needed-to-treat tells the story: you'd treat far more people with a zero score to prevent one event than people with a high score ⁴.

Two honest caveats. The power of zero is a warranty, not lifelong immunity — a minority of events still occur at zero, and the score can rise over time, which is why guidelines build in reassessment ⁴. And CAC measures calcified plaque, so it can miss early "soft" plaque and doesn't diagnose a blockage causing symptoms ³.

How doctors actually use it

This is where CAC earns its keep. The 2019 ACC/AHA primary-prevention guideline positions it as a decision tool — a tiebreaker — for intermediate-risk adults (roughly a 7.5–20% ten-year risk), typically ages 40–75, when the statin decision is genuinely uncertain ²:

• CAC 0 → reasonable to withhold or defer the statin and reassess (absent diabetes, smoking or strong family history)
• CAC 1–99 → favour a statin, particularly from age 55
• CAC ≥100 (or ≥75th percentile for your age/sex) → start a statin

It turns an abstract "your risk is 12%" into a concrete look at your own arteries — exactly the kind of shared decision people find easier to act on.

Who it's not for

CAC is a targeted tool, not a universal screen. It's generally not indicated for people already at clearly low risk, those already on a statin or with known heart disease (it won't change the plan), or the very young ³. And there's a notable nuance in the guidance: the US Preventive Services Task Force judged the evidence insufficient to add CAC to routine risk assessment for the general population, while cardiology bodies endorse selective, shared-decision use in the on-the-fence middle ⁵. The difference is population-wide screening (not supported) versus targeted use in undecided patients (supported) — which is why this is a conversation with a doctor, not a box to tick.

What we see at the clinic

The CAC scan resolves one of the most common standoffs we see in Pattaya: a man in his 50s with so-so cholesterol, a family history that worries him, and real ambivalence about starting a statin "for life." A calcium score often breaks the deadlock honestly. A zero can be genuinely liberating — solid grounds to wait and recheck — while a surprising 200 reframes the conversation and usually settles it in favour of prevention. We use it the way the guidelines intend: for intermediate-risk people where the decision is close, alongside the lipid panel, Lp(a) and the rest. We don't order it for everyone, and we're clear that zero is a warranty, not a guarantee. Interpreting it — and deciding what to do — is done with a physician who knows your whole picture.

Common questions

What does a calcium score of zero mean? No detectable calcified plaque, and a very low risk of heart events for the next decade or so ⁴. For someone undecided about a statin, it can justify safely waiting and rechecking in 5–10 years — though it's a warranty, not lifelong immunity.

If my score is high, what happens? A high score (especially ≥100, and certainly ≥400) shows established plaque and shifts the decision firmly toward prevention — statin therapy and aggressive risk-factor control ². It reframes an abstract risk into a clear reason to act.

Should everyone get a CAC scan? No. It's a decision tool for intermediate-risk adults (~40–75) who are on the fence about a statin — not for low-risk people, those already on a statin, or those with known heart disease ². The USPSTF doesn't endorse it as blanket population screening.

Is the radiation a problem? The dose is low — on the order of a few months of natural background radiation ¹. For the targeted decision it informs, that's generally considered a favourable trade-off, but it's still a reason to use it selectively rather than routinely.

Can a normal score miss anything? Yes — CAC detects calcified plaque, so it can miss early soft plaque, and it doesn't diagnose a blockage causing symptoms ³. A symptomatic person needs a different evaluation, not a calcium score.

Key takeaway

A coronary artery calcium scan is one of the best ways to turn an abstract heart-risk estimate into a direct look at your arteries — quick, low-dose, and scored 0 to 400+ by the Agatston method ¹. Its standout result is the power of zero: very low risk for years, and grounds to safely hold off on a statin in many on-the-fence people ⁴. It's a decision tool for intermediate-risk adults (~40–75), not a universal screen — and the value comes from using it selectively, with a doctor, alongside your cholesterol and Lp(a) ². When the statin question is genuinely close, few tests answer it as clearly.